Motif Bio raises £2.7 million via share placing
Motif Bio has announced that it has raised £2.7 million from a share placing, to provide additional working capital.
Read More
Tag: working capital
- Ipsen announces new data on Dysport in neurological disease
- PMGroup Worldwide Ltd welcomes MAD World Summit
- Argenx receives review from FDA for VYVGART in seronegative gMG
- Nuclera extends Series C funding to advance antibody engineering
- Cellistic launches new iPSC-based platforms to expand immuno-oncology therapies
